Dna X, Inc. (SONM) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Dna X, Inc. (SONM) stock forecast summary
Our AI scores Dna X, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Dna X, Inc. is a small-cap company with a market capitalization of $3M. It ranks number 9 by market capitalization among the 9 Telephone & Telegraph Apparatus issuers in our coverage with a current forecast. Its Current Ratio of 0.57x is the lowest of the 8 peers that report one.
For SONM, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 7.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, SONM included.
SONM price chart and AI forecast
How SONM ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Dna X, Inc. (SONM) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Telephone & Telegraph Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | SONM | Rank |
|---|---|---|
| Market Cap | $3M | 9/9 |
| EPS | $-1.61 | – |
Profitability & Margins
| Metric | SONM | Rank |
|---|---|---|
| Gross Margin | 18.1% | 6/8 |
| Operating Margin | -26.1% | 7/8 |
| EBT Margin | -28.7% | 8/8 |
| Tax Rate | -14.7% | – |
Financial Health
| Metric | SONM | Rank |
|---|---|---|
| Current Ratio | 0.57x | 8/8 |
| Interest Coverage | -5.0x | 5/6 |
| Working Capital | -$2M | 8/8 |
Cash Flow
| Metric | SONM | Rank |
|---|---|---|
| Operating Cash Flow | -$21M | 9/9 |
Operational Efficiency
| Metric | SONM | Rank |
|---|---|---|
| Payables Period | 6 days | 5/6 |
Income Statement
| Metric | SONM | Rank |
|---|---|---|
| Operating Income | -$16M | 9/9 |
| R&D Expense | $15M | 4/6 |
| SG&A Expense | $30M | 6/8 |
| Cost of Goods Sold | $43M | 6/8 |
Dividend & Shareholder Information
| Metric | SONM | Rank |
|---|---|---|
| Shares Outstanding | 1M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $3M | |
| Cash & Short-term Investments | $900K | |
| Accounts Receivable | $1M | |
| Total Liabilities | $6M | |
| Short-term Debt | $4M |
SONM quarterly financials and insider trading
Dna X, Inc. (SONM) industry peers
Companies classified under the same SEC industry code as Dna X, Inc. (Telephone & Telegraph Apparatus): 9 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere SONM sits on the market map
Dna X, Inc. (SONM) stock news
Loading...
Dna X, Inc. (SONM) stock forecast FAQ
What is the Dna X, Inc. (SONM) stock forecast?
Our AI scores Dna X, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Dna X, Inc. stock predictions?
For SONM, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 7.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -2.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Dna X, Inc. forecasts updated?
Dna X, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Dna X, Inc.'s industry peers?
9 issuers in our coverage, SONM included, share the SEC industry code Telephone & Telegraph Apparatus. The largest are: Ciena Corp (CIEN), Fabrinet (FN), Clearfield, Inc. (CLFD), Adtran Holdings, Inc. (ADTN), Audiocodes Ltd (AUDC), Franklin Wireless Corp (FKWL).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.